Warning: fopen(/home/virtual/enm-kes/journal/upload/ip_log/ip_log_2024-05.txt): failed to open stream: Permission denied in /home/virtual/lib/view_data.php on line 88 Warning: fwrite() expects parameter 1 to be resource, boolean given in /home/virtual/lib/view_data.php on line 89 Clinical Applications of Thyrotropin Binding Inhibitor Immunoglobulin (TBII) Assays.
Skip Navigation
Skip to contents

Endocrinol Metab : Endocrinology and Metabolism

clarivate
OPEN ACCESS
SEARCH
Search

Articles

Page Path
HOME > Endocrinol Metab > Volume 23(3); 2008 > Article
Editorial Clinical Applications of Thyrotropin Binding Inhibitor Immunoglobulin (TBII) Assays.
Won Bae Kim
Endocrinology and Metabolism 2008;23(3):174-178
DOI: https://doi.org/10.3803/jkes.2008.23.3.174
Published online: June 1, 2008
  • 1,749 Views
  • 19 Download
  • 3 Crossref
  • 0 Scopus
Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Korea.

Citations

Citations to this article as recorded by  Crossref logo
  • Medical Treatment of Graves' Disease
    Hyun-Kyung Chung
    International Journal of Thyroidology.2019; 12(2): 79.     CrossRef
  • When should antithyroid drug therapy to reduce the relapse rate of hyperthyroidism in Graves’ disease be discontinued?
    Suyeon Park, Eyun Song, Hye-Seon Oh, Mijin Kim, Min Ji Jeon, Won Gu Kim, Tae Yong Kim, Young Kee Shong, Doo Man Kim, Won Bae Kim
    Endocrine.2019; 65(2): 348.     CrossRef
  • Usefulness of Measuring Thyroid Stimulating Antibody at the Time of Antithyroid Drug Withdrawal for Predicting Relapse of Graves Disease
    Hyemi Kwon, Won Gu Kim, Eun Kyung Jang, Mijin Kim, Suyeon Park, Min Ji Jeon, Tae Yong Kim, Jin-Sook Ryu, Young Kee Shong, Won Bae Kim
    Endocrinology and Metabolism.2016; 31(2): 300.     CrossRef
Related articles

Endocrinol Metab : Endocrinology and Metabolism